https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-11-25 20:56:312024-11-25 20:56:31Truqap Shows Promise in Treating a Subtype of Prostate Cancer
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-11-25 11:37:462024-11-25 11:37:46Rethinking the “Lower is Better” Approach to LDL-C: Examining the Relationship Between Low LDL-C and Prostate Cancer Risk in Non-Hypertensive Men
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-11-22 09:03:082024-11-22 09:03:08Nodularin-R Enhances Abiraterone’s Effectiveness Against Castration-Resistant Prostate Cancer In Vivo
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-11-22 08:46:532024-11-22 08:47:55Olaparib’s Effectiveness Duration in Prostate Cancer Treatment
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-11-22 08:23:542024-11-22 08:23:54FDA Accepts Darolutamide Plus ADT sNDA for mHSPC Treatment
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-11-21 15:02:062024-11-21 15:02:06New Hope for Castration-Resistant Prostate Cancer: Targeting EZH2
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-11-20 22:03:592024-12-06 15:27:47Phase III Trial for Metastatic Castration-Resistant Prostate Cancer of an EZH2 inhibitor
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-11-20 21:46:412024-11-20 21:46:41AMPLITUDE phase 3 Study for Metastatic Castration-Sensitive Prostate Cancer